FDA OKs Farxiga for Heart Failure With Reduced Ejection Fraction
WEDNESDAY, May 6, 2020 -- The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday.
Farxiga is the first...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cardiology | Dapagliflozin | Food and Drug Administration (FDA) | Forxiga | General Medicine | Heart | Heart Failure